Heterologous expression of plasmodial proteins for structural studies and functional annotation

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Birkholtz, Lyn Marie ^a   Blatch, Gregory ^b   Coetzer, Theresa L ^c   Hoppe, Heinrich C ^a,d   Human, Esmaré ^a   Morris, Elizabeth J ^a,e   Ngcete, Zoleka ^a   Oldfield, Lyndon ^d   Roth, Robyn ^d   Shonhai, Addmore ^f   Stephens, Linda ^b   Louw, Abraham I ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b RHODES UNIVERSITY   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d DSI CSIR Nanotechnology Innovation Centre   (South Africa)

^e African Centre for Gene Technologies   (South Africa)

^f UNIVERSITY OF ZULULAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; FOLIC ACID ANTAGONIST; PLASMODIUM PROTEIN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN;

DRUG TARGETING; HETEROLOGOUS EXPRESSION; MALARIA; NONHUMAN; PLASMODIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR CLONING;

ANIMALS; CLONING, MOLECULAR; GENE EXPRESSION; HUMANS; PLASMODIUM; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

EID: 53949087361     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-197     Document Type: Review

References (237)

1. Integration and mining of malaria molecular, functional and phamacological data: how far are we from a chemogenomic knowledge space? LM Birkholtz O Bastien G Wells D Grando F Joubert V Kasam M Zimmermann P Ortet N Jacq N Saidani S Roy M Hofmann-Apitius V Breton AI Louw E Marechal, Malaria J 2006 17 110 10.1186/1475-2875-5-110
2. THE SOUTHEAST COLLABORATORY FOR STRUCTURAL GENOMICS (SECSG). http://www.secsg.org
3. Optimized expression of Plasmodium falciparum erythrocyte membrane protein I domains in Escherichia coli. K Flick S Ahuja A Chene MT Bejarano Q Chen, Malaria J 2004 3 1 8 10.1186/1475-2875-3-50
4. Construction and deconstruction of bacterial inclusion bodies. MM Carrio A Villaverde, J Biotechnol 2002 96 3 12 10.1016/S0168-1656(02)00032-9 12142138
5. Heterologous expression of proteins from Plasmodium falciparum: Results from 1000 genes. C Mehlin E Boni FS Buckner L Engel T Feist MH Gelb L Haji D Kim C Liu N Mueller PJ Myler JT Reddy JN Sampson E Subramanian WC Van Voorhis E Worthey F Zucker WGJ Hol, Mol Biochem Parasitol 2006 148 144 160 10.1016/j.molbiopara.2006.03.011 16644028
6. High-throughput generation of P. falciparum functional molecules by recombinational cloning. JC Aguiar J LaBaer PL Blair, Genome Res 2004 2004 2076 2082 10.1101/gr.2416604
7. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. M Vedadi J Lew J Artz M Amani Y Zhao A Dong GA Wasney M Gao T Hills S Brokx W Qiu S Sharma A Diassiti Z Alam M Melone A Mulichak A Wernimont J Bray P Loppnau O Plotnikova K Newberry E Sundararajan S Houston J Walker W Tempel A Bockharev I Kozieradzki A Edwards C Arrowsmith D Roos K Kain R Hui, Mol Biochem Parasitol 2007 151 100 110 10.1016/j.molbiopara.2006.10.011 17125854
8. Advanced genetic strategies for recombinant protein expression in Escherichia coli. HP Sorensen KK Mortensen, J Biotechnol 2005 115 113 128 10.1016/j.jbiotec.2004.08.004 15607230
9. Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. S Sahdev SK Khattar KS Saini, Mol Cell Biochem 2008 307 249 264 10.1007/s11010-007-9603-6 17874175
10. Enhancement of soluble protein expression through the use of fusion tags. D Esposito DK Chatterjee, Curr Opin Biotechnol 2006 17 353 358 10.1016/j.copbio.2006.06.003 16781139
11. Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. CJ Tonkin GG van Dooren TP Spurck NS Struck RT Good E Handman AF Cowman GI McFadden, Mol Biochem Parasitol 2004 137 13 21 10.1016/j.molbiopara.2004.05.009 15279947
12. Protein production and purification. Structural Genomics Consortium, China Structural Genomics Consortium, Northeast Structural Genomics Consortium S Gräslund P Nordlund J Weigelt BM Hallberg J Bray O Gileadi S Knapp U Oppermann C Arrowsmith R Hui J Ming S dhe-Paganon HW Park A Savchenko A Yee A Edwards R Vincentelli C Cambillau R Kim SH Kim Z Rao Y Shi TC Terwilliger CY Kim LW Hung GS Waldo Y Peleg S Albeck T Unger O Dym J Prilusky JL Sussman RC Stevens SA Lesley IA Wilson A Joachimiak F Collart I Dementieva MI Donnelly WH Eschenfeldt Y Kim L Stols R Wu M Zhou SK Burley JS Emtage JM Sauder D Thompson K Bain J Luz T Gheyi F Zhang S Atwell SC Almo JB Bonanno A Fiser S Swaminathan FW Studier MR Chance A Sali TB Acton R Xiao L Zhao LC Ma JF Hunt L Tong K Cunningham M Inouye S Anderson H Janjua R Shastry CK Ho D Wang H Wang M Jiang GT Montelione DI Stuart RJ Owens S Daenke A Schütz U Heinemann S Yokoyama K Büssow KC Gunsalus, Nature Methods 2008 5 135 146 10.1038/nmeth.f.202 18235434
13. Strategies to maximize heterologous protein expression in Eschericihia coli with minimal cost. W Peti R Page, Protein Expr Purif 2007 51 1 10 10.1016/j.pep.2006.06.024 16904906
14. Bacterial Bioreactors for High yield production of recombinant protein. M Suzuki R Roy H Zheng N Woychik M Inouye, J Biol Chem 2006 281 37559 37565 10.1074/jbc.M608806200 17020876
15. The transcriptional response of Escherichia coli to recombinant protein insolubility. HE Smith, J Struct Funct Genomics 2007 8 27 35 10.1007/s10969-007-9030-7 17992580
16. 32, reveals a multifaceted cellular response to heat stress. G Nonaka M Blankschien C Herman CA Gross VA Rhodius, Genes Dev 2006 20 1776 1789 16818608 10.1101/gad.1428206
17. Improvement in yield and purity of a recombinant malaria vaccine candidate based on the receptor-binding domain of Plasmodium vivax Duffy binding protein by codon optimization. SS Yazdani AR Shakri P Pattnaik MMA Rizvi CE Chitnis, Biotechnol Lett 2006 28 1109 1114 10.1007/s10529-006-9061-3 16794771
18. Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization. Z Zhou P Schnake L Xiao AA Lal, Protein Expr Purif 2004 34 87 94 10.1016/j.pep.2003.11.006 14766303
19. Malaria Parasite DNA. RL Coppel CG Black, Malaria parasite biology, pathogenesis and protection Washington DC: ASM Press, Sherman IW, 1998
20. Genome sequence of the human malaria parasite Plasmodium falciparum. MJ Gardner N Hall E Fung O White M Berriman RW Hyman JM Carlton A Pain KE Nelson S Bowman IT Paulsen K James JA Eisen K Rutherford SL Salzberg A Craig S Kyes M-S Chan V Nene SJ Shallom B Suh J Peterson S Angiuoli M Pertea J Allen J Selengut D Haft MW Mather AB Vaidya DMA Martin AH Fairlamb MJ Fraunholz DS Roos SA Ralph GI McFadden LM Cummings GM Subramanian C Mungall JC Venter DJ Carucci SL Hoffman C Newbold RW Davis CM Fraser B Barrell, Nature 2002 419 498 511 10.1038/nature01097 12368864
21. Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes. Z-P Feng X Zhang P Han N Arora RF Anders RS Norton, Mol Biochem Parasitol 2006 150 256 267 10.1016/j.molbiopara.2006.08. 011 17010454
22. On the abundance, amino acid composition, and evolutionary dynamics of low-complexity regions in proteins. MA DePristo MM Zilversmit DL Hartl, Gene 2006 378 19 30 10.1016/j.gene.2006.03.023 16806741
23. Overcoming codon bias: A method for high-level over expression of Plasmodium and other AT-rich parasite genes in Escherichia coli. AM Baca WGJ Hol, Int J Parasitol 2000 30 113 118 10.1016/S0020-7519(00)00019-9 10704592
24. Intrinsic Disorder and Functional Proteomics. P Radivojac LM Lakoucheva CJ Oldfield Z Obradovic VN Uversky AK Dunker, Biophys J 2007 92 1439 1456 17158572 10.1529/biophysj.106.094045
25. Expression and biochemical characterization of the Plasmodium falciparum DNA repair enzyme, flap endonuclease-1 (PfFEN-1). LJ Casta JS Buguliskis Y Matsumoto TF Taraschi, Mol Biochem Parasitol 2008 157 1 12 10.1016/j.molbiopara. 2007.08.008 17928073
26. Overproduction, crystallization and preliminary crystallographic analysis of a novel human DNA-repair enzyme that recognizes oxidative DNA damage. V Bandaru W Cooper SS Wallace S Doublie, Acta Crystallogr D Biol Crystallogr 2004 60 1142 1144 10.1107/S0907444904007929 15159582
27. The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. S Gräslund J Sagemark H Berglund LG Dahlgren A Flores M Hammarström I Johansson T Kotenyova M Nilsson P Nordlund J Weigelt, Protein Expr Purif 2008 58 210 221 10.1016/j.pep.2007.11.008 18171622
28. A novel strategy for the purification of recombinantly expressed unstructured protein domains. C Kalthoff, J Chromatogr B Analyt Technol Biomed Life Sci 2003 786 247 254 10.1016/S1570-0232(02)00908-X 12651021
29. Solution Conformation, Backbone Dynamics and Lipid Interactions of the Intrinsically Unstructured Malaria Surface Protein MSP2. X Zhang MA Perugini S Yao CG Adda VJ Murphy A Low RF Anders RS Norton, J Mol Biol 2008 379 1 105 121 10.1016/j.jmb.2008.03.039 18440022
30. Co-expression of protein complexes in prokaryotic and eukaryotic hosts: experimental procedures, database tracking and case studies. C Romier M Ben Jelloul S Albeck G Buchwald D Busso PH Celie E Christodoulou V De Marco S van Gerwen P Knipscheer JH Lebbink V Notenboom A Poterszman N Rochel SX Cohen T Unger JL Sussman D Moras TK Sixma A Perrakis, Acta Crystallogr D Biol Crystallogr 2006 62 1232 1242 10.1107/S0907444906031003 17001100
31. Vectors for co-expression of an unrestricted number of proteins. C Scheich D Kummel D Soumailakakis U Udo Heinemann K Büssow, Nucleic Acids Res 2007 35 1 7 16920744 10.1093/nar/gkm067
32. Strategies for protein coexpression in Escherichia coli. NJ Tolia L Joshua-Tor, Nature Methods 2006 3 55 64 10.1038/nmeth0106-55 16369554
33. Prediction of solubility on recombinant expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli. S Ahuja S Ahuja Q Chen M Wahlgren, Malaria J 2006 5 52 10.1186/1475-2875-5-52
34. The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. W Sirawaraporn P Prapunwattana R Sirawaraporn Y Yuthavong DV Santi, J Biol Chem 1993 268 21637 21644 8408015
35. The Plasmodium falciparum bifunctional ornithine decarboxylase, S-adenosylmethionine decaroxylase enables a well-balanced polyamine synthesis without domain-domain interaction. C Wrenger K Lüersen T Krause S Müller RD Walter, J Biol Chem 2001 276 29651 29656 10.1074/jbc.M100578200 11390378
36. WHO TDR Targets database. http://www.tdrtargets.org
37. Chemical synthesis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. P Prapunwattana R Sirawaraporn Y Yuthavong DV Santi, Mol Biochem Parasitol 1996 83 93 106 10.1016/S0166-6851(96)02756-9 9010845
38. Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine. E Angov BM Aufiero AM Turgeon M Van Handenhove CF Ockenhouse KE Kester DS Walsh JS McBride MC Dubois J Cohen JD Haynes KH Eckels DG Heppner WR Ballou CL Diggs JA Lyon, Mol Biochem Parasitol 2003 128 195 204 10.1016/S0166-6851(03)00077-X 12742586
39. Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host. E Angov CJ Hillier RL Kincaid JA Lyon, PLoS ONE 2008 3 e2189 18478103 10.1371/journal.pone.0002189
40. Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity. DL Narum S Kumar WO Rogers SR Fuhrmann H Liang M Oakley A Taye BKL Sim SL Hoffman, Infection and Immunity 2001 69 7250 7253 10.1128/IAI.69.12.7250-7253. 2001
41. Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in Prokaryotic and Eukaryotic expression systems. A Yadava CF Ockenhouse, Infect Immun 2003 71 4961 4969 12933838 10.1128/IAI.71.9.4961-4969.2003
42. Plasmodium falciparum dihydrofolate synthase-folylpolyglutamate synthase (DHFS-FPGS): Gene synthesis and recombinant expression. L Coetzee, Pretoria: University of Pretoria 2003
43. Protein expression by codon harmonization and translational attenuation. RL Kincaid E Angov JA Lyon, United States., C12P 21/02, C12N 1/21, C07H 21/04, C12N 15/74, edn San Francisco, CA, US: Veritas 2004 37
44. Ribosome-mediated translational pause and protein domain organization. TA Thanaraj P Argos, Protein Science 1996 5 1594 1612 8844849
45. Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. CJ Hillier LA Ware A Barbosa E Angov JA Lyon DG Heppner DE Lanar, Infect Immun 2005 73 2109 2115 15784552 10.1128/IAI.73.4.2109-2115.2005
46. Getting practical with molecular chaperones. VM Longshaw WS Nicoll M Botha MH Ludewig A Shonhai LL Stephens GL Blatch, Biotechnology International 2006 18 24 27
47. Hsp70 chaperones: Cellular functions and molecular mechanism. MP Mayer B Bukau, Cell Mol Life Sci 2005 62 670 684 10.1007/s00018-004-4464-6 15770419
48. Bacteria co-transformed with recombinant proteins and chaperones cloned in independent plasmids are suitable for expression tuning. A de Marco V De Marco, J Biotechnol 2004 109 45 52 10.1016/j.jbiotec.2003.10.025 15063613
49. Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. TJ Sargeant M Marti E Caler Jm Charlton K Simpson TP Speed AF Cowman, Genome Biol 2006 7 R12 16507167 10.1186/gb-2006-7-2-r12
50. The structural and functional diversity of Hsp70 proteins from Plasmodium falciparum. A Shonhai A Boshoff GL Blatch, Prot Sci 2007 16 1803 1818 10.1110/ps.072918107
51. Overproduction, purification and characterisation of the Plasmodium falciparum heat shock protein 70. TS Matambo OO Odunuga A Boshoff GL Blatch, Protein Expr Purif 2004 33 214 222 10.1016/j.pep.2003.09.010 14711509
52. Plasmodium falciparum heat shock protein 70 is able to suppress the thermosensitivity of an Escherichia coli DnaK mutant strain. A Shonhai A Boshoff GL Blatch, Mol Genet Genomics 2005 274 70 78 10.1007/s00438-005-1150-9 15973516
53. Specificity of DnaK-peptide binding. A Gragerov L Zeng X Zhao W Burkholder ME Gottesman, J Mol Biol 1994 235 848 854 10.1006/jmbi.1994.1043 8289323
54. 15-Deoxyspergualin modulates Plasmodium falciparum heat shock protein function. TNC Ramya NN Surolia A Surolia, Biochem Biophys Res Commun 2006 348 585 592 10.1016/j.bbrc.2006.07.082 16884692
55. A protein interaction network of the malaria parasite Plasmodium falciparum. DJ LaCount M Vignali R Chettier A Phansalkar R Bell JR Hesselberth LW Schoenfeld I Ota S Sahasrabudhe C Kurschner S Fields RE Hughes, Nature 2005 438 103 107 10.1038/nature04104 16267556
56. The Hsp40 proteins of Plasmodium falciparum and other apicomplexa: Regulating chaperone power in the parasite and the host. M Botha E-R Pesce GL Blatch, Int J Biochem Cell Biol 2007 39 10 1781 1803 10.1016/j.biocel.2007.02. 011 17428722
57. Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. BJ Foth SA Ralph CJ Tonkin NS Struck M Fraunholz DS Roos AF Cowman GI McFadden, Science 2003 299 705 708 10.1126/science.1078599 12560551
58. Proteases and chaperones are the most abundant proteins in the parsitophorous vacuole of Plasmodium falciparum-infected erythrocytes. J Nyalwidhe K Lingelbach, Proteomics 2006 6 1 11 10.1002/pmic.200500379
59. Maurer's clefts: A novel multi-functional organelle in the cytoplasm of Plasmodium falciparum-infected erythrocytes. M Lanzer H Wickert G Krohne L Vincensini CB Breton, Int J Parasitol 2006 36 23 36 10.1016/j.ijpara.2005.10.001 16337634
60. Induction and localization of Plasmodium falciparum stress proteins related to the heat shock protein 70 family. N Kumar G Koski M Harada M Aikawa H Zheng, Mol Biochem Parasitol 1991 48 47 58 10.1016/0166-6851(91)90163-Z 1779989
61. Protein aggregation as bacterial inclusion bodies is reversible. MM Carrio A Villaverde, FEBS Lett 2001 489 29 33 10.1016/S0014-5793(01)02073-7 11231008
62. Protein aggregation in recombinant bacteria: biological role of inclusion bodies. A Villaverde MM Carrio, Biotechnol Lett 2003 25 1385 1395 10.1023/A:1025024104862 14514038
63. Solubilization and refolding of bacterial inclusion body proteins. SM Singh AK Panda, J Biosci Bioeng 2005 99 303 310 10.1263/jbb.99.303 16233795
64. Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. LF Vallejo U Rinas, Microb Cell Fact 2004 3 11 22 15345063 10.1186/1475-2859-3-11
65. Current status of technical protein refolding. A Jungbauer W Kaar, J Biotechnol 2007 128 587 596 10.1016/j.jbiotec.2006.12.004 17222934
66. Falcipain-1, a Plasmodium falciparum Cysteine protease with vaccine potential. A Kumar K Kumar R Korde SK Puri P Malhotra VS Cauhan, Infect Immun 2007 75 2026 2034 17242063 10.1128/IAI.01533-06
67. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease Falcipain-2. PS Sijwali LS Brinen PJ Rosenthal, Protein Expr Purif 2001 22 128 134 10.1006/prep.2001.1416 11388810
68. 42) in E. coli. WH Leung ZQ Meng G Hui WKK Ho, Biochim Biophys Acta 2004 1675 62 70 15535968
69. 42) in the absence of an affinity tag. RL Shimp Jr LB Martin Y Zhang BS Henderson P Duggan NJ MacDonald J Lebowitz A Saul DL Narum, Protein Expr Purif 2006 50 58 67 10.1016/j.pep.2006.06.018 16884920
70. Non-conventional yeasts as hosts for heterologous protein production. A Dominquez E Ferminan M Sanchez J Gonzalez FM Perez-Campo S Garcia AB Herrero A San Vincente J Cabello M Prado FJ Iglesias A Choupina FJ Burguillo L Fernandez-Lago MC Lopez, Int Microbiol 1998 1 131 142 10943351
71. Protein expression in yeast as an approach to production of recombinant malaria antigens. IC Bathurst, Am J Trop Med Hyg 1994 50 20 26 8172328
72. Identification of putative Plasmodium falciparum mefloquine resistance genes. M Jeffress S Fields, Mol Biochem Parasitol 2005 139 133 139 10.1016/j.molbiopara.2004.10.005 15664648
73. Secretion of heterologous proteins directed by the yeast alpha-factor leader. AJ Brake, Biotechnology 1989 13 269 280 2679928
74. Glucose repression of the yeast ADH2 gene occurs through multiple mechanisms, including control of the protein synthesis of its transcriptional activator, ARD1. RC Vallari WJ Cook DC Audino MJ Morgan DE Jensen AP Laudano CL Denis, Mol Cell Biol 1992 12 1663 1673 1549119
75. Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials. AP Miles Y Zhang A Saul AW Stowers, Prot Express Purif 2002 25 87 96 10.1006/prep.2001.1613
76. Structural conformers produced during malaria vaccine production in yeast. AW Stowers Y Zhang RL Shimp DC Kaslow, Yeast 2001 18 137 150 10.1002/1097-0061(20010130)18:2<137::AID-YEA657>3.0.CO;2-X 11169756
77. Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast. RLB Milek HG Stunnenberg RNH Konings, Vaccine 2000 18 1402 1411 10.1016/S0264-410X(99)00392-8 10618538
78. Use of a recombinant baculovirus product to measure naturally acquired human antibodies to disulphide-constrained epitopes on the P. falciparum merozoite surface protein-1 (MSP1). MJ Blackman AA Holder, FEMS Immunol Med Microbiol 1993 6 307 315 10.1111/j.1574-695X.1993.tb00343.x 7684635
79. Protein glycosylation in yeast. W Tanner L Lehle, Biochim Biophys Acta 1987 906 81 99 3552049
80. Glycoprotein structural genomics: solving the glycosylation problem. VT Chang M Crispin AR Aricescu DJ Harvey JE Nettleship JA Fennelly C Yu KS Boles EJ Evans DI Stuart RA Dwek EY Jones RJ Owens SJ Davis, Structure 2007 15 267 273 17355862 10.1016/j.str.2007.01.011
81. Stress in recombinant protein producing yeasts. D Mattanovich B Gasser H Hohenblum M Sauer, J Biotechnol 2004 113 121 135 10.1016/j.jbiotec.2004.04.035 15380652
82. Applications of yeasts in biotechnology: protein production and genetic analysis. GPL Cereghino JM Cregg, Curr Opin Biotechnol 1999 10 422 427 10.1016/S0958-1669(99)00004-X 10508632
83. Foreign gene expression in yeast: a review. MA Romanos CA Scorer JF Clare, Yeast 1992 8 423 488 10.1002/yea.320080602 1502852
84. Novel approaches to tackling malarial drug resistance using yeast. CH Sibley I Macreadie, IUBMB Life 2001 52 285 289 10.1080/152165401317291138 11895077
85. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. DC Kaslow IC Bathurst T Lensen T Ponnudurai PJ Barr DB Keister, Infect Immun 1994 62 5576 5580 7960139
86. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. EM Malkin AP Durbin DJ Diemert J Sattabongkot Y Wu K Miura CA Long L Lambert AP Miles J Wang A Stowers LH Miller A Saul, Vaccine 2005 23 3131 3138 10.1016/j.vaccine.2004.12.019 15837212
87. Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast. II Moelans J Cohen M Marchand C Molitor P de Wilde JF van Pelt MR Hollingdale WFG Roeffene WMC Elinge CT Atkinsonf M Aikawaf JGG Schoenmakersa RNH Koningsa, Mol Biochem Parasitol 1995 72 179 192 10.1016/0166-6851(95)00072-9 8538688
88. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae. C Hirunpetcharat JH Tian DC Kaslow N van Rooijen S Kumar JA Berzofsky LH Miller MF Good, J Immunol 1997 159 3400 3411 9317139
89. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. S Kumar A Yadava DB Keister JH Tian M Ohl KA Perdue-Greenfield LH Miller DC Kaslow, Mol Med 1995 1 325 332 8529111
90. EUROSCARF. http://web.uni-frankfurt.de/fb15/mikro/euroscarf/
91. Saccharomyces Genome Deletion Project. http://www-sequence.stanford.edu/ group/yeast_deletion_project/
92. ATCC. http://www.atcc.org/
93. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. SK Volkman AF Cowman DF Wirth, Proc Natl Acad Sci USA 1995 92 8921 8925 7568044 10.1073/pnas.92.19.8921
94. Proteolipid of vacuolar H+-ATPase of Plasmodium falciparum : cDNA cloning, gene organization and complementation of a yeast null mutant. S Yatsushiro S Taniguchi T Mitamura H Omoto Y Moriyama, Biochim Biophys Acta 2005 1717 89 96 10.1016/j.bbamem.2005.08.011 16293223
95. Ammonia permeability of the aquaglyceroporins from Plasmodium falciparum, Toxoplasma gondii and Trypanosoma brucei. T Zeuthen B Wu S Pavlovic-Djuranovic LM Holm NL Uzcategui M Duszenko JF Kun JE Schultz E Beitz, Mol Microbiol 2006 61 1598 1608 10.1111/j.1365-2958.2006.05325.x 16889642
96. The Plasmodium falciparum PfGatp is an endoplasmic reticulum membrane protein important for the initial step of malarial glycerolipid synthesis. TC Santiago R Zufferey RS Mehra RA Coleman C Ben Mamoun, J Biol Chem 2004 279 9222 9232 10.1074/jbc.M310502200 14668349
97. Characterization of the phosphatidylinositol synthase gene of Plasmodium species. K Wengelnik HJ Vial, Res Microbiol 2007 158 51 59 10.1016/j.resmic. 2006.11.005 17223316
98. In vivo evidence for the specificity of Plasmodium falciparum phosphoethanolamine methyltransferase and its coupling to the Kennedy pathway. G Pessi JY Choi JM Reynolds DR Voelker CB Mamoun, J Biol Chem 2005 280 12461 12466 10.1074/jbc.M414626200 15664981
99. The GPI1 homologue from Plasmodium falciparum complements a Saccharomyces cerevisiae GPI1 anchoring mutant. H Shams-Eldin N Azzouz MH Kedees P Orlean T Kinoshita RT Schwarz, Mol Biochem Parasitol 2002 120 73 81 10.1016/S0166- 6851(01)00434-0 11849707
100. Plasmodium falciparum histone acetyltransferase, a yeast GCN5 homologue involved in chromatin remodelling. Q Fan L An L Cui, Eukar Cell 2004 3 264 276 10.1128/EC.3.2.264-276.2004
101. Plasmodium falciparum protein phosphatase 1 functionally complements a glc7 mutant in Saccharomyces cerevisiae. MK Bhattacharyya Z Hong D Kongkasuriyachai N Kumar, Int J Parasitol 2002 32 739 747 10.1016/S0020-7519(02) 00007-3 12062492
102. Characterisation of the Cdc2-related kinase 2 gene from Plasmodium knowlesi and P. berghei. R Vinkenoog M Aparecida Sperança J Ramesar AW Thomas HA del Portillo CJ Janse AP Waters, Mol Biochem Parasitol 1998 95 229 240 10.1016/S0166-6851(98)00104-2 9803415
103. Functional complementation of yeast ribosomal P0 protein with Plasmodium falciparum P0. K Aruna T Chakraborty PN Rao C Santos JPG Ballesta S Sharma, Gene 2005 357 9 17 10.1016/j.gene.2005.04.007 16099608
104. Analysis of the vitamin B6 biosynthesis pathway in the human malaria parasite Plasmodium falciparum. C Wrenger ML Eschbach IB Muller D Warnecke RD Walter, J Biol Chem 2005 280 5242 5248 10.1074/jbc.M412475200 15590634
105. A bifunctional dihydrofolate synthetase-folylpolyglutamate synthetase in Plasmodium falciparum identified by functional complementation in yeast and bacteria. E Salcedo JF Cortese CV Plowe PFG Sims JE Hyde, Mol Biochem Parasitol 2001 112 239 252 10.1016/S0166-6851(00)00370-4 11223131
106. Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210. EG Hankins DC Warhurst CH Sibley, Mol Biochem Parasitol 2001 117 91 102 10.1016/S0166-6851(01)00335-8 11551635
107. Novel Plasmodium vivax dhfr alleles from the Indonesian archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. MD Hastings JD Maguire MJ Bangs PA Zimmerman JC Reeder JK Baird CH Sibley, Antimicrob Agents Chemother 2005 49 733 740 15673758 10.1128/AAC.49.2.733-740.2005
108. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum : analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210. JT Ferlan S Mookherjee IN Okezie L Fulgence CH Sibley, Mol Biochem Parasitol 2001 113 139 150 10.1016/S0166-6851(01)00207-9 11254962
109. Efficacies of lipophilic inhibitors of dihydrofolate reductase against parasitic protozoa. H Lau JT Ferlan VH Brophy A Rosowsky CH Sibley, Antimicrob Agents Chemother 2001 45 187 195 11120964 10.1128/AAC.45.1.187-195.2001
110. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum. LY Djapa LK Basco L Zelikson A Rosowsky JA Djaman JN Yonkeu M Bolotin-Fukuhara A Mazabraud, Mol Biochem Parasitol 2007 156 89 92 10.1016/j.molbiopara.2007.07.009 17727978
111. Engineering of non-conventional yeasts for efficient synthesis of macromolecules: the methyltrophic genera. S Houard M Heinderyckx A Bollen, Biochimie 2002 84 1089 1093 10.1016/S0300-9084(02)00011-1 12595136
112. Posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate. B Giersing K Miura R Shimp J Wang H Zhou A Orcutt A Stowers A Saul LH Miller C Long S Singh, Infect Immun 2005 73 3963 3970 15972483 10.1128/IAI.73.7.3963-3970.2005
113. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. L Zou AP Miles J Wang AW Stowers, Vaccine 2003 21 1650 1657 10.1016/S0264-410X(02)00701-6 12639486
114. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA 1): production and activity of an AMA1 vaccine and generation of a multiallelic response. MC Kennedy J Wang Y Zhang AP Miles F Chitsaz A Saul CA Long LH Miller AW Stowers, Infect Immun 2002 70 6948 6960 12438374 10.1128/IAI.70.12.6948-6960.2002
115. High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. CH Kocken MA Dubbeld A van der Wel JT Pronck AP Waters JAM Langermans AW Thomas, Infect Immun 1999 67 43 49 9864194
116. 19, an important vaccine antigen for malaria, epressed in the methyltropic yeast Pichia pastoris. CP Brady RL Shimp Jr AP Miles M Whitmore AW Stowers, Protein Expr Purif 2001 23 468 475 10.1006/prep.2001.1526 11722185
117. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro. W Pan D Huang Q Zhang L Qu D Zhang X Zhang X Xue F Qian, J Immunol 2004 172 6167 6174 15128804
118. Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1. BW Faber EJ Remarque WD Morgan CH Kocken AA Holder AW Thomas, Infect Immun 2007 75 5947 5955 17938224 10.1128/IAI.01804-06
119. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites. D Zhang P Weiqing, Infect Immun 2005 73 6530 6536 16177327 10.1128/IAI.73.10.6530-6536.2005
120. Construction and evaluation of a multistage combination vaccine against malaria. D Zhang X Xue L Qu W Pan, Vaccine 2007 25 2112 2119 10.1016/j.vaccine.2006.11.015 17241708
121. Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris. CW Tsai PF Duggan RL Shimp LH Miller DL Narum, J Biotechnol 2006 121 458 470 10.1016/j.jbiotec.2005.08.025 16274825
122. Changing the N-terminal sequence protects recombinant Plasmodium falciparum circumsporozoite protein from degradation in Pichia pastoris. Q Zhang F Ding X Xue X Xu P Weiqing, Appl Microbiol Biotechnol 2008 78 139 145 10.1007/s00253-007-1294-0 18097661
123. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. AW Stowers MC Kennedy BP Keegan A Saul CA Long LH Miller, Infect Immun 2002 70 6961 6967 12438375 10.1128/IAI.70.12.6961-6967.2002
124. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. EM Malkin DJ Diemert JH McArthur JR Perrault AP Miles BK Giersing GE Mullen A Orcutt O Muratova M Awkal H Zhou J Wang A Stowers CA Long S Mahanty LH Miller A Saul AP Durbin, Infect Immun 2005 73 3677 3685 15908397 10.1128/IAI.73.6.3677-3685.2005
125. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. T Arakawa A Komesu H Otsuki J Sattabongkot R Udomsangpetch Y Matsumoto N Tsuji Y Wu M Torii T Tsuboi, Infect Immun 2005 73 7375 7380 16239536 10.1128/IAI.73.11.7375-7380.2005
126. Immunogenicity of C-terminus of Plasmodium falciparum merozoite surface protein 1 expressed as a non-glycosylated peptide in yeast. ZG Zhang WG Yu WS Qiu HM Zhao, Acta Biochim Biophys Sin 2006 38 403 409 10.1111/j.1745-7270.2006. 00178.x 16761098
127. Improved yield of recombinant merozoite surface protein 3 (MSP3) from Pichia pastoris using chemically defined media. J Wang V Nguyen J Glen B Henderson A Saul LH Miller, Biotechnol Bioeng 2005 90 838 847 10.1002/bit.20491 15849695
128. The antimalarial drug resistance protein Plasmodium falciparum chloroquine resistance transporter binds chloroquine. H Zhang M Paguio PD Roepe, Biochem 2004 43 8290 8296 10.1021/bi049137i
129. Analysis of the antimalarial drug resistance protein Pfcrt expressed in yeast. H Zhang EM Howard PD Roepe, J Biol Chem 2002 277 49767 49775 10.1074/jbc.M204005200 12351620
130. Heterologous expression and ATPase activity of mutant versus wild type PfMDR1 protein. LE Amoah JK Lekostaj PD Roepe, Biochemistry 2007 46 6060 6073 10.1021/bi7002026 17469853
131. Functional reconstitution of purified chloroquine resistance membrane transporter expressed in yeast. W Tan DM Gou E Tai YZ Zhao LMC Chow, Arch Biochem Biophys 2006 452 119 128 10.1016/j.abb.2006.06.017 16884678
132. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. TA Kost JP Condrey DL Jarvis, Nature Biotechnol 2005 23 567 575 10.1038/nbt1095
133. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. SP Chang HL Gibson CT Lee-Ng PJ Barr GS Hui, J Immunol 1992 149 548 555 1624802
134. Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum : a malaria vaccine candidate. JC Pizarro V Chitarra D Verger I Holm S Pêtres S Dartevelle F Nato S Longacre GA Bentley, J Mol Biol 2003 328 1091 1103 10.1016/S0022-2836(03)00376-0 12729744
135. Expression of hybrid malaria antigens in insect cells and their engineering for correct folding and secretion. VF Murphy WC Rowan MJ Page AA Holder, Parasitology 1990 100 177 183 2189112
136. Plasmodium falciparum : recombinant baculoviruses direct the expression of circumsporozoite proteins in Spodoptera frugiperda cell cultures. P Jacobs M Massaer M Heinderyckx F Milican P Gilles O van Opstal P Voet D Gheysen A Bollen, Mol Biol Rep 1991 15 73 79 10.1007/BF00364842 1749376
137. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. L Barfod NL Bernasconi M Dahlbäck D Jarrossay PH Andersen A Salanti MF Ofori L Turner M Resende MA Nielsen TG Theander F Sallusto A Lanzavecchia L Hviid, Mol Microbiol 2007 63 335 347 10.1111/j.1365-2958.2006.05503.x 17176260
138. Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies. JR Daugherty CI Murphy LA Doros-Richert A Barbosa LO Kashala WR Ballou NJ Snellings CF Ockenhouse DE Lanar, Infect Immun 1997 65 3631 3637 9284129
139. A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. H Liang DL Narum SR Fuhrmann T Luu BK Sim, Infect Immun 2000 68 3564 3568 10816512 10.1128/IAI.68.6.3564-3568.2000
140. Ion-exchange-immunoaffinity purification of a recombinant baculovirus Plasmodium falciparum apical membrane antigen, PF83/AMA-1. DL Narum GW Welling AW Thomas, J Chromatogr 1993 657 357 363 10.1016/0021-9673(93)80291-F
141. Characterisation of proteases involved in the processing of Plasmodium falciparum serine repeat antigen (SERA). J Li H Matsuoka T Mitamura T Horii, Mol Biochem Parasitol 2002 120 177 186 10.1016/S0166-6851(01)00452-2 11897123
142. The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum. F Teuscher J Lowther TS Skinner-Adams T Spielmann MW Dixon CM Stack S Donnelly A Mucha P Kafarski S Vassiliou DL Gardiner JP Dalton KR Trenholme, J Biol Chem 2007 282 30817 30826 10.1074/jbc.M704938200 17720817
143. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development. CM Stack J Lowther E Cunningham S Donnelly DL Gardiner KR Trenholme TS Skinner-Adams F Teuscher J Grembecka A Mucha P Kafarski L Lua A Bell JP Dalton, J Biol Chem 2007 282 2069 2080 10.1074/jbc.M609251200 17107951
144. Functional characterization of the propeptide of Plasmodium falciparum subtilisin-like protease-1. L Jean F Hackett SR Martin MJ Blackman, J Biol Chem 2003 278 28572 28579 10.1074/jbc.M303827200 12764150
145. von Willebrand Factor A domain-related protein, a novel microneme protein of the malaria ookinete highly conserved throughout Plasmodium parasites. M Yuda K Yano T Tsuboi M Torii Y Chinzei, Mol Biochem Parasitol 2001 116 65 72 10.1016/S0166-6851(01)00304-8 11463467
146. Plasmodium falciparum : glycosylation status of Plasmodium falciparum circumsporozoite protein expressed in the baculovirus system. MH Kedees N Azzouz P Gerold H Shams-Eldin J Iqbal V Eckert RT Schwarz, Exp Parasitol 2002 101 64 68 10.1016/S0014-4894(02)00030-9 12243739
147. Protein glycosylation in the malaria parasite. DC Gowda EA Davidson, Parasitol Today 1999 15 147 152 10.1016/S0169-4758(99)01412-X 10322336
148. In Vivo Expression and immunological studies of the 42-Kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the Baculovirus-Silkworm system. ALY Pang CN Hashimoto LQ Tam ZQ Meng GSN Hui WKK HO, Infect Immun 2002 70 2772 2779 12010962 10.1128/IAI.70.6.2772-2779.2002
149. An Online Informatics Resource for Dictyostelium. http://www.dictybase. org
150. Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT. B Naudé JA Brzostowski AR Kimmel TE Wellems, J Biol Chem 2005 280 25596 25603 15883156 10.1074/jbc.M503227200
151. Multiple splice variants encode a novel adenylyl cyclase of possible plastid origin expressed in the sexual stage of the malaria parasite Plasmodium falciparum. DK Muhia CA Swales U Eckstein-Ludwig S Saran SD Polley JM Kelly P Schaap S Krishna DA Baker, J Biol Chem 2003 278 22014 22022 10.1074/jbc. M301639200 12668669
152. Anchoring of an immunogenic Plasmodium falciparum circumsporozoite protein to the surface of Dictyostelium discoideum. CD Raymond C Beghdadi-Rais M Roggero EA Duarte C Desponds M Bernard D Groux H Matile C Bron G Corradin NJ Fasel, J Biol Chem 1995 270 12941 12947 10.1074/jbc.270.21.12941 7759554
153. Gene organization features in A/T-rich organisms. K Szafranski R Lehmann G Parra R Guigo G Glöckner, J Mol Evol 2005 60 90 98 10.1007/s00239-004- 0201-2 15696371
154. Dictyostelium discoideum as an expression host for the circumsporozoite protein of Plasmodium falciparum. N Fasel C Begdadi-Rais M Bernard C Bron G Corradin CD Reymond, Gene 1992 111 157 163 10.1016/0378-1119(92)90683-G 1541397
155. Expression and one-step purification of Plasmodium proteins in Dictyostelium. MX Van Bemmelen C Beghdadi-Rais C Desponds E Vargas S Herrera CD Reymond N Fasel, Mol Biochem Parasitol 2000 111 377 390 10.1016/S0166-6851(00) 00330-3 11163444
156. Toxoplasma gondii : the model apicomplexan. K Kim LM Weiss, Int J Parasitol 2004 34 423 432 10.1016/j.ijpara.2003.12.009 15003501
157. Motile systems in malaria merozoites: how is the red blood cell invaded? JC Pinder RE Fowler LH Bannister AR Dluzewski GH Mitchell, Parasitol Today 2000 16 240 245 10.1016/S0169-4758(00)01664-1 10827429
158. The Plasmodium falciparum Vps4 homolog mediates multivesicular body formation. M Yang I Coppens S Wormsley P Baevova HC Hoppe KA Joiner, J Cell Sci 2004 117 3831 3838 10.1242/jcs.01237 15252121
159. Transformed Toxoplasma gondii tachyzoites expressing the circumsporozoite protein of Plasmodium knowlesi elicit a specific immune response in Rhesus monkeys. M Di Cristina F Ghouze CH Kocken S Naitza P Cellini D Soldati AW Thomas A Crisanti, Infect Immun 1999 67 1677 1682 10085003
160. Recombinant attenuated Toxoplasma gondii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria. H Charest M Sedegah GS Yap RT Gazzinelli P Caspar SL Hoffman A Sher, J Immunol 2000 165 2084 2092 10925293
161. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): Antiparasitic activity of a PKG inhibitor. CA Diaz J Allocco MA Powles L Yeung RGK Donald JW Anderson PA Liberator, Mol Biochem Parasitol 2006 146 78 88 10.1016/j.molbiopara.2005.10.020 16325279
162. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. BK Sim CE Chitnis K Wasniowska TJ Hadley LH Miller, Science 1994 264 1941 1944 10.1126/science.8009226 8009226
163. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. NH Tolia EJ Enemark BKL Sim L Joshua-Tor, Cell 2005 122 183 193 10.1016/j.cell.2005.05.033 16051144
164. Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx. K Kato DCG Mayer S Singh M Reid LH Miller, Proc Natl Acad Sci USA 2005 102 5552 5557 15805191 10.1073/pnas.0501594102
165. Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells. TS Fraser SHI Kappe DL Narum KM VanBuskirk JH Adams, Mol Biochem Parasitol 2001 117 49 59 10.1016/S0166-6851(01)00326-7 11551631
166. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. KM VanBuskirk E Sevova JH Adams, Proc Natl Acad Sci USA 2004 101 15754 15759 15498870 10.1073/pnas.0405421101
167. Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion. HJ Han SG Park SH Kim SY Hwang J Han J Traicoff WG Kho JY Chung, Biochem Biophys Res Comm 2004 320 563 570 10.1016/j.bbrc.2004.06.008 15219866
168. Polymorphism in a Plasmodium falciparum erythrocyte-binding ligand changes its receptor specificity. DCG Mayer JB Mu X Feng X-z Su LH Miller, J Exp Med 2002 196 1523 1528 12461087 10.1084/jem.20020750
169. Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity. DCG Mayer JB Mu O Kanedo J Duan X-z Su LH Miller, Proc natl Acad Sci USA 2004 101 2518 2523 14983041 10.1073/pnas.0307318101
170. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. T Wickramarachchi YS Devi A Mohmmed VS Chauhan, PLoS ONE 2008 3 e1732 18320051 10.1371/journal.pone.0001732
171. Identification of a 67-amino acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates. B Gamain JD Smith M Avril DI Baruch A Scherf J Gysin LH Miller, Mol Microbiol 2004 53 445 455 10.1111/j.1365-2958.2004.04145.x 15228526
172. Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane proten-1 identifies a CD36 binding domain. JD Smith S Kyes AG Craig T Fagan D Hudson-Taylor LH Miller DI Baruch CI Newbold, Mol Biochem Parasitol 1998 97 133 148 10.1016/S0166-6851(98)00145-5 9879893
173. Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. JD Smith AG Craig N Kriek D Hudson-Taylor S Kyes T Fagen R Pinches DI Baruch CI Newbold LH Miller, Proc Natl Acad Sci USA 2000 97 1766 1771 10677532 10.1073/pnas.040545897
174. Further definition of PfEMP-1 DBL-1α domains mediating rosetting adhesion of Plasmodium falciparum. C Russell O Mercereau-Puijalon C Le Scanf M Steward DE Arnot, Mol Biochem Parasitol 2005 144 109 113 10.1016/j.molbiopara. 2005.06.009 16122820
175. The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes. B Gamain LH Miller DI Baruch, Proc Natl Acad Sci USA 2001 98 2664 2669 11226296 10.1073/pnas.041602598
176. Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya. EA Ohas JH Adams JN Waitumbi ASS Orago A Barbosa DE Lanar JA Stoute, Infect Immun 2004 72 735 741 14742515 10.1128/IAI.72.2.735-741.2004
177. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. CR Collins C Withers-Martinez GA Bentley AH Batchelor AW Thomas MJ Blackman, J Biol Chem 2007 282 7431 7441 10.1074/jbc.M610562200 17192270
178. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. A Rainczuk T Scorza TW Spithill PM Smooker, Infect Immun 2004 72 5565 5573 15385453 10.1128/IAI.72.10.5565-5573.2004
179. Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. KR Qazi M Wikman NM Vasconcelos K Berzins S Ståhl C Fernández, Vaccine 23 1114 1125 10.1016/j.vaccine.2004.08.033 15629354
180. A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230. SL Fanning B Czesny M Sedegah DJ Carucci GJ van Gemert W Eling KC Williamson, Vaccine 2003 21 3228 3235 10.1016/S0264-410X(03)00265-2 12804852
181. Induction of biologically active antibodies in mice, rabbits, and monkeys by Plasmodium falciparum EBA-175 region II DNA vaccine. BKL Sim DL Narum H Liang SR Fuhrman N Obaldia R Gramzinski J Aguiar JD Haynes JK Moch SL Hoffman, Mol Med 2001 7 247 254 11471569
182. Characterization of Plasmodium falciparum CDP-diacylglycerol synthase, a proteolytically cleaved enzyme. D Martin L Gannoun-Zaki S Bonnefoy P Eldin K Wengelnik H Vial, Mol Biochem Parasitol 2000 110 93 105 10.1016/S0166-6851(00) 00260-7 10989148
183. Functional analysis of the first mannosyltransferase (PIG-M) involved in glycosylphosphatidylinositol synthesis in Plasmodium falciparum. YU Kim Y Hong, Mol Cells 2007 24 294 300 17978585
184. Plasmodium falciparum histidine-rich protein II binds to actin, phosphatidylinositol 4,5-bisphosphate and erythrocyte ghosts in a pH-dependent manner and undergoes coil-to-helix transitions in anionic micelles. CE Benedetti J Kobarg TA Pertinhez RM Gatti OM de Souza A Spisni R Meneghini, Mol Biochem Parasitol 2003 128 157 166 10.1016/S0166-6851(03)00057-4 12742582
185. Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine. HHG Van Es S Karcz F Chu AF Cowman S Vidal P Gros E Schurr, Mol Cell Biol 1994 14 2419 2428 7511206
186. Chloroquine-resistant isoforms of the Plasmodium falciparum chloroquine resistance transporter acidify lysosomal pH in HEK293 cells more than chloroquine-sensitive isoforms. DC Reeves DA Liebelt V Lakshmanan PD Roepe DA Fidock MH Akabas, Mol Biochem Parasitol 2006 150 288 299 17014918 10.1016/j.molbiopara.2006.09.001
187. Expression of substrate-specific transporters encoded by Plasmodium falciparum in Xenopus laevis oocytes. JI Penny ST Hall CJ Woodrow GM Cowan AM Gero S Krishna, Mol Biochem Parasitol 1998 93 81 89 10.1016/S0166-6851(98)00024- 3 9662030
188. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. CJ Woodrow JI Penny S Krishna, J Biol Chem 1999 274 7272 7277 10.1074/jbc.274.11.7272 10066789
189. Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model. SK Manning C Woodrow FA Zuniga P Iserovich J Fischbarg AI Louw S Krishna, J Biol Chem 2002 277 30942 30949 10.1074/jbc.M204337200 12042321
190. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family. T Joët L Holterman TT Stedman CHM Kocken A van der Wel AW Thomas S Krishna, Biochem J 2002 368 923 929 12238947 10.1042/BJ20021189
191. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives. M Fayolle M Ionita S Krishna C Morin AP Patel, Bioorg Med Chem Lett 2006 16 1267 1271 10.1016/j.bmcl.2005.11. 068 16361099
192. Purine nucleobase transport in the intraerythrocytic malaria parasite. MJ Downie KJ Saliba S Bröer SM Howitt K Kirk, Int J Parasitol 2008 38 203 209 10.1016/j.ijpara.2007.07.005 17765902
193. Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum. NS Carter C Ben Mamoun W Liu EO Silva SM Landfear DE Goldberg B Ullman, J Biol Chem 2000 275 10683 10691 10.1074/jbc.275.14.10683 10744765
194. Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy. MD Parker RJ Hyde L McRobert CE Cass JD Young GA McConkey SA Baldwin, Biochem J 2000 349 67 75 10861212 10.1042/0264-6021:3490067
195. Transport of nucleosides across the Plasmodium falciparum parasite plasma membrane has characteristics of PfENT1. MJ Downie KJ Saliba SM Howitt S Bröer K Kirk, Mol Microbiol 2006 60 738 748 10.1111/j.1365-2958.2006.05125. x 16629674
196. Sodium-dependent uptake of inorganic phosphate by the intracellular malaria parasite. KJ Saliba RE Martin A Bröer RI Henry S McCarthy MJ Downie RJW Allen KA Mullin GI McFadden S Bröer K Kirk, Nature 2006 443 582 585 17006451
197. A single, bi-functional aquaglyceroporin in blood-stage Plasmodium falciparum malaria parasites. M Hansen JFJ Kun JE Schultz E Beitz, J Biol Chem 2002 277 4874 4882 10.1074/jbc.M110683200 11729204
198. Aquaglyceroporin PbAQP during intraerythrocytic development of the malaria parasite Plasmodium berghei. D Promeneur Y Liu J Maciel P Agre LS King N Kumar, Proc Natl Acad Sci USA 2007 104 2211 2216 17284593 10.1073/pnas. 0610843104
199. Artemisinins target the SERCA of Plasmodium falciparum. U Eckstein-Ludwig RJ Webb DA van Goethem JM East AG Lee M Kimura PM O'Neill PG Bray SA Ward S Krishna, Nature 2003 424 957 961 10.1038/nature01813 12931192
200. Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. S Krishna C Woodrow R Webb J Penny K Takeyasu M Kimura JM East, J Biol Chem 2001 276 10782 10787 10.1074/jbc.M010554200 11145964
201. Evidence for activation of endogenous transporters in Xenopus laevis oocytes expressing the Plasmodium falciparum chloroquine resistance transporter, PfCRT. S Nessler O Friedrich N Bakouh RHA Fink CP Sanchez G Planelles M Lanzer, J Biol Chem 2004 279 39438 39446 10.1074/jbc.M404671200 15258157
202. Regulation of protein phosphatase type 1 and cell cycle progression by PfLRR1, a novel leucine-rich repeat protein of the human malaria parasite Plasmodium falciparum. W Daher E Browaeys C Pierrot H Jouin D Dive E Meurice C Dissous M Capron S Tomavo C Doerig K Cailliau J Khalife, Mol Microbiol 2006 60 578 590 10.1111/j.1365-2958.2006.05119.x 16629662
203. Expression of Plasmodium falciparum C-terminal region of merozoite surface protein (PfMSP119), a potential malaria vaccine candidate in tobacco. S Ghosh P Malhotra PV Lalitha S Guha-Mukherjee VS Chauhan, Plant Science 2002 162 335 343 10.1016/S0168-9452(01)00555-6
204. Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam. L Wang TL Richie A Stowers D Hanh Nhan RL Coppel, Infect Immun 2001 69 4390 4397 11401978 10.1128/IAI.69.7.4390-4397.2001
205. Cell-free translation systems for protein engineering. Y Shimizu Y Kumura BW Ying S Umekage T Ueda, FEBS J 2006 273 4133 4140 10.1111/j.1742-4658.2006. 05431.x 16930131
206. Wheat germ cell-free platform for eukaryotic protein production. DA Vinarov CL Loushin L Newman JL Markley, FEBS J 2006 273 4160 4169 10.1111/j.1742-4658.2006.05434.x 16930128
207. Cell-free production of functional Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. DG Mudeppa CKT Pang T Tsuboi E Endo FS Buckner G Varani R PK, Mol Biochem Parasitol 2007 151 216 219 10.1016/j.molbiopara.2006. 10.016 17157934
208. Wheat germ cell-free system based production of malaria proteins for discovery of Novel Vaccine candidates. T Tsuboi S Takeo H Iriko L Jin M Tsuchimochi s Matsuda ET Han H Otsuki O Kaneko J Sattabongkot R Udomsangpetch T Sawasaki M Torii Y Endo, Infect Immun 2008 76 1702 1708 18268027 10.1128/IAI.01539-07
209. Advancements in transfection technologies for Plasmodium. B Bhalu JH Adams, Int J Parasitol 2007 37 1 10 10.1016/j.ijpara.2006.10.001 17113093
210. Whole-transcriptome analysis of Plasmodium falciparum field isolates: identification of new pathogenicity factors. A Siau FS Touré O Ouwe-Missi-Oukem-Boyer L Cicéron N Mahmoudi C Vaquero P Froissard U Bisvigou S Bisser JY Coppée E Bischoff PH David D Mazier, J Infect Dis 2007 196 1603 1612 10.1086/522012 18008243
211. Functional expression of ribozymes in Apicomplexa: towards exogenous control of gene expression by inducible RNA-cleavage. C Agop-Nersesian J Pfahler M Lanzer M Meissner, Int J Parasitol 2008 38 673 681 10.1016/j.ijpara.2007.10. 015 18062972
212. Two Plasmodium falciparum ribonucleotide reductase small subunits, PfR2 and PfR4, interact with each other and are components of the in vivo enzyme complex. V Bracchi-Ricard D Moe D Chakrabarti, J Mol Biol 2005 347 749 759 10.1016/j.jmb.2005.01.051 15769467
213. Malarial dihydroorotate dehydrogenase substrate inhibitor and specificity. J Baldwin AM Farajallah NA Malmquist PK Rathod MA Phillips, J Biol Chem 2002 277 41827 41834 10.1074/jbc.M206854200 12189151
214. Identification, cloning, and mutational analysis of the casein kinase 1 cDNA of the malaria parasite, Plasmodium falciparum. S Barik RE Taylor D Chakrabarti, J Biol Chem 1997 272 26132 26138 10.1074/jbc.272.42.26132 9334178
215. Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. PM Faber LD Arscott CH Williams K Becker RH Schirmer, FEBS Lett 1998 422 311 314 10.1016/S0014-5793(98)00031-3 9498806
216. The thioredoxin system of the malaria parasite Plasmodium falciparum. SM Kanzok RH Schirmer I Turbachova R Iozef K Becker, J Biol Chem 2000 275 40180 40186 10.1074/jbc.M007633200 11013257
217. Structures of P. falciparum PfPK5 test the CKD regulation paradigm and suggest mechnisms of small molecule inhibition. S Holton A Merckx D Burgess C Doerig M Noble J Endicott, Structure 2003 11 1329 1337 10.1016/j.str.2003.09.020 14604523
218. Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors. E Droucheau A Primot V Thomas D Mattei M Knockaert C Richardson P Salllicandro P Alano A Jafarshad B Baratte C Kunick D Parzy L Pearl C Doerig L Meijer, Biochim Biophys Acta 2004 1697 181 196 15023360
219. PfPKB, a Novel Protein Kinase B-like Enzyme from Plasmodium falciparum. A Kumar A Vaid C Syin P Sharma, J Biol Chem 2004 279 24255 24264 10.1074/jbc.M312855200 15024016
220. Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases. CM Li PC Tyler RH Furneaux G Kicska Y Xu C Grubmeyer ME Girvin VL Schramm, Nat Struct Biol 1999 6 6 582 587 10.1038/9367 10360365
221. DNA polymerase δ: gene sequences from Plasmodium falciparum indicate that this enzyme is more highly conserved than DNA polymerase α RG Ridley JH White SM McAleese M Goman P Alano E de Vries BJ Kilbey, Nucleic Acids Res 1991 24 6731 6736 10.1093/nar/19.24.6731
222. In the human parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase. S Muller A Da'dara K Luersen C Wrenger R Das Gupta R Madhubala RD Walter, J Biol Chem 2000 275 8097 8102 10.1074/jbc.275.11.8097 10713131
223. Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum. DK Shoemark MJ Cliff RB Sessions AR Clarke, FEBS J 2007 274 2738 2748 10.1111/j.1742-4658.2007.05808.x 17459101
224. Plasmodium falciparum : Enhanced soluble expression, purification and biochemical characterization of lactate dehydrogenase. R Berwal N Gopalan K Chandel GBKS Prasad S Prakash, Exp Parasitol 2008 18619439
225. Purification and Characterization of Recombinant Plasmodium falciparum Adenylosuccinate Synthetase Expressed in Escherichia coli. R Jayalakshmi K Sumathy H Balaram, Protein Expr Purif 2002 25 65 72 10.1006/prep.2001.1610 12071700
226. Molecular characterization of Plasmodium falciparum S-adenosylmethionine synthetase. PH Chiang ME Chamberlin D Nicholson S Soubes XZ Su G Subramanian DE Lanar ST Prigge JP Scovill LH Miller JY Chou, Biochem J 1999 344 571 576 10567242 10.1042/0264-6021:3440571
227. X-ray structure of Plasmepsin II complexed with a potent achiral inhibitor. L Prade AF Jones C Boss S Richard-Bilstein S Meyer C Binkert D Bur, J Biol Chem 2005 280 23837 23843 10.1074/jbc.M501519200 15840589
228. Characterization of N-myristoyltransferase from Plasmodium falciparum. RS Gunaratne M Sajid IT Ling R Tripathi JA Pachebat AA Holder, Biochem J 2000 348 459 463 10816442 10.1042/0264-6021:3480459
229. The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin. R Kumar A Musiyenko S Barik, Malaria J 2003 2 1 11 10.1186/1475-2875-2-30
230. Glutamate dehydrogenase, the marker protein of Plasmodium falciparum. JT Wagner H Ludemann PM Färber F Lottspeich RL Krauth-Siegel, Eur J Biochem 1998 258 813 819 10.1046/j.1432-1327.1998.2580813.x 9874251
231. The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs. C Werner MT Stubbs RL Krauth-Siegel G Klebe, J Mol Biol 2005 349 587 607 10.1016/j.jmb.2005.03.077
232. Cloning of the triosephosphate isomerase gene of Plasmodium falciparum and expression in Escherichia coli. J Ranie VP Kumar H Balaram, Mol Biochem Parasitol 1993 61 159 169 10.1016/0166-6851(93)90062-3 7903426
233. Plasmodium falciparum S-Adenosylhomocysteine hydrolase. cDNA identification, predicted protein sequence and expression in Escherichia coli. KA Creedon KR Pradipsinh TE Wellems, J Biol Chem 1994 269 16364 16370 8206944
234. Crystal Structure of S-Adenosyl-l-Homocysteine Hydrolase from the Human Malaria Parasite Plasmodium falciparum. N Tanaka M Nakanishi Y Kusakabe K Shiraiwa S Yabe Y Ito Y Kitade KT Nakamura, J Mol Biol 2004 343 1007 1017 10.1016/j.jmb.2004.08.104 15476817
235. Expression, purification and crystallization of the Plasmodium falciparum enoyl reductase. SP Muench JB Rafferty R McLeod DW Rice ST Prigge, Acta Crystallogr D Biol Crystallogr 2003 59 1246 1248 10.1107/S0907444903008813 12832774
236. Molecular cloning and nuclear localization of a histone deacetylase homologue in Plasmodium falciparum. MB Joshi DT Lin PH Chiang ND Goldman H Fujioka M Aikawa C Syin, Mol Biochem Parasitol 1999 99 11 19 10.1016/S0166-6851(98)00177-7 10215020
237. Biochemical characterization and crystallization of recombinant 3-phosphoglycerate kinase of Plasmodium falciparum. B Pal B Pybus DD Muccio Chattopadhyay, Biochim Biophys Acta 2004 1699 277 280 15158737